SLIDE 1 Save this presentation Feel free to add or delete slides as necessary, change information to suit local needs and as new guidance or evidence is published
Disclaimer: Whilst the working group has made every effort to ensure the accuracy of information provided the ICNA and 3M cannot be responsible for any alterations made by users to the presentation to meet local needs.
Instructions for use
SLIDE 2
SLIDE 3
Understand the impact and causes of infection associated with vascular access Identify signs and symptoms of infection in vascular access Explain procedures involved with safe insertion, maintenance and removal of intravascular devices to reduce the risks of infection
Objectives
SLIDE 4 9% of hospital inpatients at any one time will acquire an infection during their stay1 There are at least 100,000 HAI a year1 5,000 deaths a year2 Financial impact
- 1. Auditor General (2000) the management and control of Hospital Acquired Infection in Acute NHS in England.
- 2. DOH CMO (England) (2002) Getting ahead of the curve
The Impact of Healthcare Associated Infection (HCAI)
SLIDE 5 National Audit Office
– Suggests that 10-15% of HCAI can be prevented – Good application of Infection Control policies and principles
National Audit Office 2000
Preventing HCAI
SLIDE 6
Incidence of blood stream infections
– 0-15% (Elliott 1993) – Central catheters responsible for 31% hospital bacteraemias, peripheral lines 7% (PHLS 2000) – Paediatrics: 3-11 / 1000 catheter days (Seguin et al. 1994)
The extent of the problem
SLIDE 7 Up to 80% of hospitalised patients will receive some form
- f I.V. therapy (Wilkinson 1996)
Nystrom et al. (1983) studied 10,616 surgical patients.
– 63% had an I.V. device – 10.34% thrombophlebitis
The extent of the problem (2)
SLIDE 8
General Principles of Infection Control
Remove the source of infection Block routes of spread Enhance the patient’s resistance to infection
SLIDE 9
Patient Factors External Factors
Risk Factors for Infections
SLIDE 10
Local infection
– Local inflammation – Discharge around line – Erythema – Pain/discomfort
Systemic infection
– Fever – Rigors when line is in use – Tachycardia – Metastatic infection
Vascular Access Associated Infections
SLIDE 11 Coagulase – Negative Staphylococci (CNS) 30-40% Staphylococcus aureus 5-10%. Enterococcus 4-6%. Pseudomonas aeruginosa 2-6%. Candida 2-5%; Enterbacter 1-4%; Acinetobacter 1-2%; Serratia <1%
Centres for disease Control and Prevention (2002) Guidelines for the Prevention of Intravascular catheter – related Infections. Morbidity and Mortality weekly report. Vol. 51/ No. RR-10.
Common pathogens in bacteraemia
SLIDE 12
Endogenous
– Infection arising from patient’s own organisms
Exogenous
– Infection originating from organism outside of the patient’s body including environment, equipment & staff hands
Routes of Infection
SLIDE 13
Intrinsic contamination occurs prior to the use of the equipment
– manufacturing problem, poor storage
Extrinsic contamination occurs at any point during the insertion, use or removal of the device
– Poor hand hygiene, poor aseptic technique
Sources of Exogenous Infection
SLIDE 14
Extraluminal
– Organisms access the vein via outside of catheter
Intraluminal
– Organisms access the vein via lumen of catheter
Haematogenous
– Organisms from other sites transferred by blood flow to catheter
Extraluminal, intraluminal & haematogenous routes
SLIDE 15
HAEMATOGENOUS SEEDING SKIN COLONISATION
SLIDE 16
epic National Evidence Guidelines for Infection Control NICE Infection Control prevention of HCAI in primary and community care ICNA Guidelines for Preventing Intravascular Catheter- Related Infections
Guidelines
SLIDE 17
Other national resources
Winning Ways Savings Lives
SLIDE 18
Provide service in best interest to patient / client
– Policies based on national standards and guidelines
Necessary skills and competence Provide care in partnership
– Patient / carer information
Evaluate
– Practice, clinical outcomes
Report
– Adverse outcomes, limitations
Professional Issues
SLIDE 19
Assessment of need Line choice Insertion site choice Insertion technique Site care Line management Asepsis Hand hygiene
Principles of PIVA
SLIDE 20
Does the patient need I.V. access
– Alternative administration of therapy
What treatment is to be administered
– Influence catheter type
Assessment of need
SLIDE 21 Peripheral line (PVC)
Ported vs. unported
Peripherally Inserted Central Catheter (PICC) Other alternative e.g. vascuports Paediatric: Umbilical catheters
Line choice
SLIDE 22 Central line (CVC)
Single lumen unless multiple ports essential Use tunnelled catheter or implantable port for long term devices
(more than 30 days)
Consider antimicrobial impregnated CVC for high risk adult
patients who require short-term treatment (less than 10 days)
Line choice (2)
SLIDE 23
Assess risks for infection against risk of mechanical complications Use subclavian line as a preference unless medically contraindicated Consider using PICC as alternative to subclavian or jugular access PVC – site choice where least mechanical irritation
Insertion site choice (adult)
SLIDE 24 Assess risks for infection against risk of mechanical complications Most CVCs will be jugular or femoral (subclavian
Consider using PICC as alternative to subclavian or jugular access PVC – site choice where least mechanical irritation
Insertion site choice (paediatric)
SLIDE 25
Aseptic technique Standard precautions utilised 70% Isopropyl Alcohol skin preparation
Insertion technique – PVC
SLIDE 26 Full aseptic technique Full body drape with access to insertion site only Full surgical attire by operator and assistant (epic 2001) Alcoholic chlorhexidine skin preparation (alcoholic poviodine-iodine solution for patients with history
- f chlorhexidine sensitivity)
Allow the antiseptic to dry before inserting catheter
Insertion technique – CVC
SLIDE 27
Intact sterile, transparent, semi-permeable polyurethane dressing CVC dressing changed every 7 days or sooner if it becomes wet, loose or soiled Before accessing the system disinfect external surfaces of the catheter hub and connection ports with alcoholic chlorhexidine gluconate or povidone-iodine unless contraindicated by manufacturer
Site care
SLIDE 28
Insertion sites should be checked at least daily for signs of inflammation and document using VIP score
Site care (2)
SLIDE 29
Lines should be handled as little as possible Injection ports should be disinfected with alcohol wipes Replace all tubing when vascular device is changed Change tubing, stopcocks etc no more frequently than every 72-96 hours (unless clinically indicated) Replace tubing from blood transfusion within 24 hours of initiation and on completion Replace tubing following infusion of lipids within 24 hours of initiation
Line management
SLIDE 30 Asepsis is defined as the method by which microbial contamination is prevented during invasive procedures or
- f breaches in the skin’s integrity
Aseptic techniques are methods that have been developed to ensure that only uncontaminated objects / fluids make contact with sterile / susceptible sites
Asepsis
Full compliance with aseptic technique is essential for handling any line
SLIDE 31
Compliance with aseptic technique must be used to insert all central lines Skin should be disinfected before inserting any catheter
– Alcoholic chlorhexidine gluconate (alcoholic povidone-iodine in sensitivity) for CVC and PICC – Alcohol wipe for PVC – Allow preparation to dry before insertion
Use sterile gloves for CVC manipulation (based on risk assessment) Hands must be decontaminated prior to any line manipulation / intervention
Aseptic technique
SLIDE 32
Hand hygiene is the principle factor to reduce risks of introducing micro-organisms Hands must be washed / decontaminated before and after any manipulation / intervention associated with the line
– Administering drugs, changing infusions, inserting lines, changing dressings
Hands must be washed after removing gloves
Hand hygiene
SLIDE 33 Soap and water
Wet hands Wash using Ayliffe 6 step technique Rinse Dry thoroughly
– To remove physical dirt / organic matter
Alcohol based hand rubs
– Physically clean hands – In absence of appropriate hand washing facilities
Hand care
Hand hygiene (2)
SLIDE 34
Hand hygiene (3)
SLIDE 35
Patients / carers should be trained how to look after a long term line
– Reducing risks of infection – Identifying signs and symptoms of infection – How to report concerns
Patient information
SLIDE 36 Surveillance
– Site infection surveillance (incidence, rates) – Bloodstream infection associated with vascular devices
Mandatory bacteraemia reporting
– Root-cause analysis
Infection prevented?
SLIDE 37 Audit
– Practices, local and organisational
Insertion, management, documentation
Department of Health, ICNA audit tool Saving Lives
– High impact intervention No. 1 & 2
PIVA audit tools
Infection prevented? (2)
SLIDE 38
Infection prevention and control is everybody’s responsibility every day!
SLIDE 39
Any Questions? Thank you for listening!